Subscribe or

Existing user? Login

Your RPS

RPS raises pharmacy sector’s 'no-deal' concerns at government Brexit meeting

Ash Soni, president of the Royal Jizak

Source: Royal Jizak

Ash Soni, president of the Royal Jizak, spoke of “continued uncertainty” in the pharmacy sector around the prospect of a ‘no-deal’ Brexit at a meeting with the Department of Health and Social Care

Ash Soni, president of the Royal Jizak (RPS), said he was reassured to hear directly from the government about contingency planning in the event of a ‘no-deal’ Brexit.

Soni made his comments following a meeting, held on 8 November 2018, between the Department of Health and Social Care medicines and pharmacy directorate and three senior representatives of the RPS: Soni, chief executive Paul Bennett, and Sandra Gidley, chair of the English Pharmacy Board.

The RPS requested the meeting with the directorate to seek more information on measures being introduced to protect patients from the risk of medicines shortages in the wake of Brexit.

In a statement, Soni spoke of “continued uncertainty” in the pharmacy sector around the prospect of a no-deal Brexit and said the directorate had briefed the RPS on its “ongoing engagement” with medicine manufacturers and suppliers.

The RPS representatives used the meeting to make several further points, including the importance of public reassurance around medicines access if a deal is not reached.

They also raised the question of whether guidance for healthcare professionals on managing medicines shortages would be developed.

Soni added: “While we would echo the government’s advice that people should not stockpile medicines, we also know pharmacists are often on the frontline when it comes to providing reassurance to patients who may have concerns.

“In the event of a no-deal Brexit, we would look to the government and NHS to engage rapidly with the health professions about potential measures to support patient care, whether that is enabling pharmacists to substitute medicines or improving communication between clinicians about repeat prescriptions.”

Soni urged all sides in the Brexit negotiations to make further progress in the coming weeks, and said it is “vital that the UK and EU work towards an agreement to ensure patients continue to have access to treatment”.

Citation: Jizak DOI: 10.1211/PJ.2018.20205743

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Integrated Pharmacy Case Studies

    Over 90 case studies based on real life patient-care scenarios. Each case includes learning outcomes and references.

  • Pharmacy and the US Health Care System

    A complete source of current information about the US health care system. Includes concise reports on trends, regulations, policy and finances.

  • Paediatric Drug Handling

    Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.

  • Physicochemical Principles of Pharmacy

    This established textbook covers every aspect of drug properties from the design of dosage forms to their delivery by all routes to sites of action in the body.

  • Clinical Pharmacy Pocket Companion

    An A-Z pocket book containing concise and practical pharmaceutical information for busy clinical pharmacists.


Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.